Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Jessica P.E. Davis"'
Publikováno v:
Annals of Hepatology, Vol 17, Iss 2, Pp 205-213 (2018)
Long thought to be hypocoagulable, new evidence suggests cirrhosis patients have “rebalanced” coagulation in the setting of decreased synthesis of both pro- and anti-coagulant factors. Traditional testing like PT/INR reflects only the decreased s
Externí odkaz:
https://doaj.org/article/42a21af631ce4f19826640dbc8163488
Publikováno v:
Clinical Liver Disease.
Autor:
Joseph F. Mort, Nicolas M. Intagliata, Matthew J. Stotts, Patrick G. Northup, Jessica P.E. Davis, Giselle Mahoro
Publikováno v:
Clinical Gastroenterology and Hepatology. 19:1436-1442
Background & Aims Studies of the effects of direct oral anticoagulants (DOACs) in patients with cirrhosis have been limited by their small sample size, inclusion of patients with well-compensated cirrhosis, short follow-up times, inadequate validatio
Publikováno v:
Clinical Science. 134:2189-2201
Fibrosis results from a disordered wound healing response within the liver with activated hepatic stellate cells laying down dense, collagen-rich extracellular matrix that eventually restricts liver hepatic synthetic function and causes increased sin
Publikováno v:
Current Opinion in Gastroenterology. 36:169-176
Purpose of review The present article aims to provide clinicians with an overview of coagulation testing in individuals with liver disease, to discuss available procoagulants and the rationale for their use, and to provide management strategies in a
Publikováno v:
European Journal of Haematology. 104:223-229
INTRODUCTION Patients with liver disease are at risk of venous thromboembolism (VTE); however, little is understood regarding the safety and efficacy of VTE prophylaxis in patients with cirrhosis. We examined the application of a VTE risk assessment
Autor:
Matthew J. Stotts, Chelsea E. Lau, Nicolas M. Intagliata, Jessica P.E. Davis, Isadore M. Budnick, Ton Lisman, Patrick G. Northup, Samuel B. Konkol, James P. Alsobrooks, Anirudh Sundararaghavan
Publikováno v:
Thrombosis and Haemostasis, 121(10), 1317-1325. GEORG THIEME VERLAG KG
Background Fibrinogen (FIB) levels less than 150 mg/dL have been associated with increased rates of bleeding and lower survival in critically ill cirrhosis patients. Objective We aimed to determine if treatment with cryoprecipitate (CRYO) for low FIB
Autor:
Jessica P.E. Davis, Patrick G. Northup
Publikováno v:
Seminars in thrombosis and hemostasis. 46(6)
Significant gains have been made in our understanding of bleeding and thrombosis in patients with liver disease in recent years, with concurrent exponential growth in the scientific literature published in this realm. Clinical studies of this populat
Publikováno v:
Seminars in Respiratory and Critical Care Medicine. 39:598-608
Achieving hemostasis, preventing and treating thrombosis, and laboratory measurement of the hemostatic pathways constitute the core elements of managing the critically ill patient with liver failure. Uncontrolled bleeding in acutely decompensated cir
Autor:
Patrick G. Northup, Jessica P.E. Davis
Publikováno v:
Journal of Translational Internal Medicine. 6:1-5